Hallmarks of senescence and aging

被引:205
|
作者
Dodig, Slavica [1 ]
Cepelak, Ivana [1 ]
Pavic, Ivan [2 ,3 ]
机构
[1] Univ Zagreb, Fac Pharm & Biochem, Dept Med Biochem & Hematol, Zagreb, Croatia
[2] Childrens Hosp Zagreb, Dept Pulmonol Allergol & Immunol, Zagreb, Croatia
[3] Univ Zagreb, Sch Med, Zagreb, Croatia
关键词
senescence; aging; biomarkers; hallmarks; AGE-RELATED DISEASE; REGULATORY T-CELLS; CELLULAR SENESCENCE; TELOMERE LENGTH; SECRETORY PHENOTYPE; OXIDATIVE STRESS; BIOMARKER; IMMUNOSENESCENCE; HETEROGENEITY; INFLAMMATION;
D O I
10.11613/BM.2019.030501
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The complex process of biological aging, as an intrinsic feature of living beings, is the result of genetic and, to a greater extent, environmental factors and time. For many of the changes taking place in the body during aging, three factors are important: inflammation, immune aging and senescence (cellular aging, biological aging). Senescence is an irreversible form of long-term cell-cycle arrest, caused by excessive intracellular or extracellular stress or damage. The purpose of this cell-cycles arrest is to limit the proliferation of damaged cells, to eliminate accumulated harmful factors and to disable potential malignant cell transformation. As the biological age does not have to be in accordance with the chronological age, it is important to find specific hallmarks and biomarkers that could objectively determine the rate of age of a person. These biomarkers might be a valuable measure of physiological, i.e. biological age. Biomarkers should meet several criteria. For example, they have to predict the rate of aging, monitor a basic process that underlies the aging process, be able to be tested repeatedly without harming the person. In addition, biomarkers have to be indicators of biological processes, pathogenic processes or pharmacological responses to therapeutic intervention. It is considered that the telomere length is the weak biomarker (with poor predictive accuracy), and there is currently no reliable biomarker that meets all the necessary criteria.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Aging hallmarks, biomarkers, and clocks for personalized medicine: (re) positioning the limelight
    Polidori, M. Cristina
    FREE RADICAL BIOLOGY AND MEDICINE, 2024, 215 : 48 - 55
  • [42] Aging hallmarks, biomarkers, and clocks for personalized medicine: (re) positioning the limelight
    Polidori, M. Cristina
    FREE RADICAL BIOLOGY AND MEDICINE, 2024, 215 : 48 - 55
  • [43] The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks
    Aunan, Jan R.
    Cho, William C.
    Soreide, Kjetil
    AGING AND DISEASE, 2017, 8 (05): : 628 - 642
  • [44] Lysosomes in senescence and aging
    Tan, Jay Xiaojun
    Finkel, Toren
    EMBO REPORTS, 2023, 24 (11)
  • [45] Telomeres, cellular senescence, and aging: past and future
    Eppard, Madeline
    Passos, Joao F.
    Victorelli, Stella
    BIOGERONTOLOGY, 2024, 25 (02) : 329 - 339
  • [46] Senescence in Pulmonary Fibrosis: Between Aging and Exposure
    Venosa, Alessandro
    FRONTIERS IN MEDICINE, 2020, 7
  • [47] Reflections on the role of senescence during development and aging
    Triana-Martinez, F.
    Pedraza-Vazquez, G.
    Maciel-Baron, L. A.
    Konigsberg, M.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2016, 598 : 40 - 49
  • [48] Connective Tissue and Fibroblast Senescence in Skin Aging
    Wlaschek, Meinhard
    Maity, Pallab
    Makrantonaki, Evgenia
    Scharffetter-Kochanek, Karin
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (04) : 985 - 992
  • [49] The Link Between Epigenetic Clocks for Aging and Senescence
    Wagner, Wolfgang
    FRONTIERS IN GENETICS, 2019, 10
  • [50] Senescence and Aging: Does It Impact Cancer Immunotherapies?
    Maggiorani, Damien
    Beausejour, Christian
    CELLS, 2021, 10 (07)